- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
美沙拉嗪对活动性溃疡性结肠炎的疗效观察.doc
美沙拉嗪对活动性溃疡性结肠炎的疗效观察
摘 要 目的:考察美沙拉嗪对活动性溃疡性结肠炎患者炎症相关因子和血小板计数的影响。方法:将89例活动性溃疡性结肠炎患者分为观察组(美沙拉嗪肠溶片治疗,45例)和对照组(柳氮磺胺吡啶治疗,44例),比较两组治疗效果和不良反应发生情况。结果:治疗后,观察组患者治疗有效率(93.33%)明显高于对照组(70.45%),而观察组炎症指标(IL-6、IL-1、TNF-α)和血小板计数均明显低于对照组,两组比较差异具有统计学意义(P0.05),且全部患者治疗后的上述指标水平较治疗前均明显降低,治疗前后比较差异均具有显著性(P0.05);治疗过程中,观察组不良反应发生比例明显低于对照组(P0.05)。结论:美沙拉嗪对活动性溃疡性结肠炎具有确切的治疗效果,可明显降低患者炎症因子水平和抑制血小板活化状态。
关键词 美沙拉嗪 溃疡性结肠炎 炎症因子 血小板
中图分类号:R971.1; R574.62 文献标识码:B 文章编号:1006-1533(2014)15-0025-03
Observation of the curative effect of mesalazine on active ulcerative colitis*
LIU Yichao**, YI Kewei, LI Na
(Xiangya Mine Cooperation Hospital of Pingxiang, Jiangxi Province, Pingxiang 337000, China)
ABSTRACT Objective: To study the effect of mesalazine on inflammation-associated cytokines and platelet count in patients with active ulcerative colitis. Methods: Eighty-nine cases of patients with active ulcerative colitis were divided into an observation group (treated with mesalazine tablets, n=45) and a control group (treated with sulfasalazine, n=44) and the effects and adverse reaction were compared between two groups. Results: After treatment, the efficiency was significantly higher in the observation group (93.33%) than in the control group (70.45%), and the inflammation markers such as IL-6, IL-1, TNF- α and the platelet count were significantly lower in the observation group than in the control group (P0.05), moreover, index levels above-mentioned in all patients were significantly decreased after treatment as compared with those before treatment (P0.05). Adverse reaction was significantly lower in the observation group than in the control group (P0.05) during treatment. Conclusion: Mesalazine has a good effect in the treatment of active ulcerative colitis and can significantly decrease the levels of inflammatory factors and inhibit the activation of platelet in patients.
KEY WORDS mesalazine; ulcerative colitis; inflammatory factor; platelet
活动性溃疡性结肠炎是指处于活动期的结直肠非特异性慢性炎症性肠道疾病,其病因和发病
您可能关注的文档
最近下载
- 城管执法队员百分制考核细则.docx VIP
- 高血压的诊治PPT课件.pptx VIP
- 第二单元第04课时用混合运算解决实际问题(1)(教学课件)数学人教版三年级上册(新教材).pptx
- 健身会所操课教练工作流程及规范 .pdf VIP
- 《江苏省工业、建筑业、服务业、生活和农业用水定额(2025年)》.docx VIP
- 国投证券-固态电池系列报告(一):未来已来固态电池行业迎来产业驱动.pdf VIP
- Hubsan哈博森无人机ZINO说明书用户手册.pdf
- 高中政治必修二《经济与社会》选择题专练30题 .pdf VIP
- 高危高尿酸血症药物降尿酸治疗专家共识(2025版).pptx VIP
- 2025湖南郴州桂阳县招聘25名城市社区专职工作者笔试备考题库及答案解析.docx VIP
文档评论(0)